Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
|
|
| 16.80 Delayed Data As of Sep 29 |  -0.03 / -0.18%Today’s Change | 10.08 Today|||52-Week Range 17.48 | +37.70% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Venrock Associates |  Sale | 2/17/2016 | 237,699 | $14.25 | $3.4M | +18.39% |
Ggv Capital Director | Sale | 7/29/2016 | 177,488 | $15.03 | $2.7M | +13.59% |
Venrock Associates | Sale | 2/19/2016 | 150,000 | $13.71 | $2.1M | +23.62% |
Venrock Associates | Sale | 2/18/2016 | 112,301 | $13.82 | $1.6M | +20.69% |
Zollars Robert J Director | Sale | 9/01/2016 | 65,500 | $15.99 | $1.0M | +5.33% |
Zollars Robert J Director | Sale | 7/29/2016 | 65,500 | $14.50 | $949.8K | +13.59% |
Zollars Robert J Director | Sale | 8/02/2016 | 53,012 | $14.57 | $772.4K | +13.59% |
Ggv Capital | Sale | 2/12/2016 | 19,664 | $15.01 | $295.2K | +19.66% |
Duffy Mary Bridget Chief Medical Officer | Sale | 3/01/2016 | 18,560 | $13.65 | $253.3K | +22.18% |
Duffy Mary Bridget Chief Medical Officer | Sale | 3/02/2016 | 16,753 | $14.09 | $236.0K | +16.42% |
